Bone marrow non-mesenchymal mononuclear cells induce functional differentiation of neuroblastoma cells by unknown
Experimental 
Hematology & Oncology
Phruksaniyom et al. Experimental Hematology & Oncology 2013, 2:9
http://www.ehoonline.org/content/2/1/9LETTER TO THE EDITOR Open AccessBone marrow non-mesenchymal mononuclear
cells induce functional differentiation of
neuroblastoma cells
Chareerut Phruksaniyom1, Permphan Dharmasaroja1* and Surapol Issaragrisil2Abstract
Less is known about the non-mesenchymal mononuclear cell fraction of human bone marrow on functional
adaptation of neuroblastoma cells. Using immunocytochemistry, we showed that bone-marrow mononuclear cell
(BMMC)-conditioned medium can induce tyrosine hydroxylase expression in neuroblastoma cells, which is similar to
the effect of retinoic acid. Using quantitative RT-PCR, we showed that NGF, CNTF, and BDNF mRNAs were detected
in unfractionated BMMC populations from all human donors at different expression levels. Our results suggest that
cells of the non-mesenchymal mononuclear cell fraction can induce functional adaptation of neuroblastoma cells,
probably via their secreted trophic factors.
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Many studies investigating the possible therapeutic role
of bone marrow-derived stem cells (BMDCs) used a
specific subpopulation: the bone marrow mesenchymal
stromal cells (MSCs) obtained after several weeks in cul-
tures [1], or the mononuclear fraction (BMMC; bone
marrow mononuclear cells) obtained immediately after
aspiration. Cells of the hematopoietic stem cell fraction,
when transplanted into lesions of a developing spinal
cord in a chicken embryo, can differentiate into neurons
[2]. The capacity of BMMCs to generate neural cells
is poorly characterized. Several studies indicate an over-
lap in the molecular programs for hematopoiesis and
neuropoiesis in mice [3,4]. Primary CD34+ human
hematopoietic stem cells (HSCs) have been shown to
express mRNA for a number of proteins that are used
by neurons [5].
Evidence has indicated that human SH-SY5Y neuro-
blastoma cells changed into neuron-like phenotypes with
reduced proliferation by all-trans retinoic acid (ATRA)
[6], and treatment with RA increased protein expression* Correspondence: permphan.dha@mahidol.ac.th
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distribution, and reproduction in any mediumof tyrosine hydroxylase (TH) in neuroblastoma cells [7].
Using a co-culture method, human MSCs promoted the
survival and neuritogenesis of neuroblastoma cells,
similar to that of ATRA [8]. Less is known about the
mononuclear cell fraction of human bone marrow on
functional adaptation of neuroblastoma cells.
We hypothesize that cells of the BMMC fraction can
induce functional adaptation of neuroblastoma cells,
probably via their secreted trophic factors. First, we eval-
uated the effect of cells of the human BMMC fraction
on the expression of TH protein in neuroblastoma cells
by culturing SH-SY5Y cells in BMMC-conditioned
medium. Human bone marrow samples were aspirated
from healthy donors after obtaining informed consent
and ethical approval by the Siriraj Ethics Committee of
Siriraj Hospital. After isolation, the mononuclear cells
were plated at a concentration of 1.5 × 105 cells/ml onto
flasks containing low glucose-DMEM supplemented
with 10% fetal bovine serum (FBS). After incubation for
72 h, non-adherent cells were collected for culture in
MEM/F12 medium supplemented with 10% FBS. After
an additional 24 h, non-adherent cells were collected
again and cultured in the medium as described above.
After 24 h, non-adherent cell-conditioned medium was
collected for further experiment. SH-SY5Y cells wereentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Immunostaining micrographs using a confocal microscope demonstrate localization of the tyrosine hydroxylase (TH). Cells
were stained with polyclonal antibody against TH and immunostained with Alexa 488-conjugated secondary antibody (green) and nuclei were
stained with DAPI (blue). CM, BMMC-conditioned medium; RA, retinoic acid.
Figure 2 Quantitative expression of NGF, CNTF, and BDNF
mRNAs in cells of the BMMC fraction obtained from three
healthy donors. 20 ng cDNA was used as PCR template. Real-time
PCR mixture was prepared with KAPA SYBRW FAST qPCR master mix.
β-actin was used as the reference gene. Each bar represents mean ±
SD from triplicate of each sample. The expression levels were scaled
relative to the lowest unscaled expression level for the same gene
as the sample of interest.
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medium at an initial density of 1 × 104 cells/ml, and cul-
tures were maintained for 7 days prior to analysis of TH
expression using immunocytochemistry. As a positive
control, cells were treated with 10 μM ATRA for 5 days
to induce neuronal differentiation. With estimated con-
centration of 35 ± 2 × 104 cells/ml for staining, the re-
sults showed that BMMC-conditioned medium can
induce TH protein expression in neuroblastoma cells
(Figure 1C), which is similar to the effect of ATRA
(Figure 1B). Untreated cells did not express TH or
expressed at very low levels (Figure 1A).
Further, we evaluated whether cells of the BMMC frac-
tion expressed any trophic factors that could contribute
to biochemical adaptation of neuroblastoma cells.
Monocytes in the human bone marrow have been shown
to produce nerve growth factor (NGF), which plays an
important role in neuronal plasticity, maturation, and
survival [9]. Human monocytes, T cells, and B cells can
secrete brain-derived neurotrophic factor (BDNF), a
member of the neurotrophin family that regulates the
differentiation and survival of various neuronal popula-
tions [10]. Ciliary neurotrophic factor (CNTF), another
factor involved in neurogenesis, is also expressed in
monocytes, myeloid cells, lymphoblasts, T cells and B
cells [11]. Here, we evaluated the mRNA expression of
NGF, BDNF, and CNTF in BMMCs using quantitative
RT-PCR. The sequences of the sense and antisense
primers are as follows: NGF: TAAAAAGCGGCGACT
CCGTT and ATTCGCCCCTGTGGAAGATG; CNTF:
ACCAGCAGGTGCATTTTACC and GAAACGAAGGTCATGGATGG; BDNF: ACTCTGGAGAGCGTGAA
TGG and ATCCAACAGCTCTTCTATCACG; β-actin:
CATGTACGTTGCTATCCAGGC and CTCCTTAATG
TCACGCACGAT. The results showed that NGF, CNTF,
and BDNF mRNAs were detected in unfractionated
BMMC populations from all donors at different expres-
sion levels (Figure 2). Their expression levels were rather
low, suggesting that not all but only some populations of
the cells expressed these trophic factors.
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step of the biosynthesis pathway of dopamine and nor-
adrenaline, in SH-SY5Y cells by BMMC-conditioned
media suggests the functional differentiation of the cells.
ATRA can also induce responsiveness to BDNF in SH-
SY5Y cells [12]. Our results imply that expression and
secretion of BDNF from cells in the mononuclear frac-
tion may explain the similar effects of RA and BMMC-
conditioned media. BMDCs constitutively synthesize
and secrete NGF, BDNF, and CNTF. Multiple cell types,
however, are present in the BMMC fraction. Primary
CD34+ human HSCs express mRNA for a number of
proteins, including receptors for trophic factors and
other mediators involved in the development of neurons
[5]. Most of the CD34+ cells are progenitors for myeloid
and lymphoid lineages, which express some trophic
factors, such as CNTF [11], that were also observed in
our quantitative RT-PCR results. Further studies are
required to quantify the contribution of trophic factors
to BMMC-induced effects on functional adaptation of
neuroblastoma cells, which could have clinical relevance
in treatment of neuroblastoma.
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